课题基金 / 基金详情

Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques

Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques
用于恒河猴药物测定或重复、低剂量攻击研究的相关猿猴免疫缺陷病毒 (SIV) 库存的扩展和表征
批准号:
10903691
负责人:
PETER SILVERA
金额:
$0.15万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-16 至 2022-01-31

项目摘要

项目成果

PETER SILVERA的其他基金

相似基金

相关文献

中文摘要
翻译
杀菌剂和生物医学预防综合资源合同的目的是为NIAID提供一整套临床前产品开发服务,用于研究人员发起的研究或与外部公司或组织合作产生的候选产品。承包商应提供:1)临床前填补服务;2)支持产品开发的HIV动物模型;3)生物分析支持服务;4)产品制造;5)科学和质量/监管支持服务。
英文摘要
The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Expertise in Development of Pediatric Drug Formulations
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
海外基金